UK issues allergy warning over Pfizer Covid-19 vaccine after two adverse reactions
4 years, 3 months ago

UK issues allergy warning over Pfizer Covid-19 vaccine after two adverse reactions

India Today  

Britain's medicine regulator has advised that people with a history of significant allergic reactions do not get Pfizer-BioNTech's Covid-19 vaccine after two people reported adverse effects on the first day of rollout. Britain began mass vaccinating its population on Tuesday in a global drive that poses one of the biggest logistical challenges in peacetime history, starting with the elderly and frontline workers National Health Service medical director Stephen Powis said the advice had been changed after two NHS workers reported anaphylactoid reactions associated with receiving the vaccine. "As is common with new vaccines the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination, after two people with a history of significant allergic reactions responded adversely yesterday," Powis said. "The fact that we know so soon about these two allergic reactions and that the regulator has acted on this to issue precautionary advice shows that this monitoring system is working well," he said.

Vaccine Pfizer Reactions Allergic  covid19  pfizer  regulator  vaccine  issues  vaccines  warning  uk  mhra  history  allergic  adverse  reported  significant  reactions  allergy

History of this topic

Health chiefs 'failed to sound alarm over potential dangers of Covid vaccines': MPs accuse regulator of putting Brits 'at serious risk' by not immediately sharing how Pfizer jabs could trigger extreme
1 year, 1 month ago

Health chiefs 'failed to sound alarm over potential dangers of Covid vaccines': MPs accuse regulator of putting Brits 'at serious risk' by not immediately sharing how Pfizer jabs could trigger extreme

Daily Mail  

Britain's medicines regulator has been accused of failing to sound the alarm over Covid jab side effects, despite allegedly knowing of heart risks for months before warnings were issued. The AAPG letter, penned by its co-chair Graham Stringer the Labour MP for Blackley and Broughton, called for an urgent investigation to be held into The Medicines and Healthcare products Regulatory …

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots
1 year, 6 months ago

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots

India Today  

The U.S. Food and Drug Administration on Monday authorized updated Covid-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the coronavirus, paving the way for the launch later this week of a fall vaccination campaign. Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 subvariant of the virus, were expected to be available …

COVID-19 pill Paxlovid moves closer to full FDA approval
2 years ago

COVID-19 pill Paxlovid moves closer to full FDA approval

Associated Press  

WASHINGTON — Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. The agency asked its panel of independent medical experts to address several …

UK Approves Pfizer Bivalent Covid Vaccine Ahead of Booster Drive
2 years, 6 months ago

UK Approves Pfizer Bivalent Covid Vaccine Ahead of Booster Drive

News 18  

The UK’s drug regulator said Saturday it had approved an updated Covid-19 jab by Pfizer/BioNTEch targeting the original virus and a subvariant ahead of an autumn booster drive. The UK Medicines and Healthcare products Regulatory Agency approved the Pfizer jab as a booster for those aged 12 and over after a “careful review of the evidence”. MHRA chief executive June …

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study
2 years, 10 months ago

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study

India TV News  

A fourth dose of the Pfizer or Moderna COVID-19 vaccine is safe and boosts antibody levels, even higher than that of a third dose, according to the latest results from a nationwide study in the UK. The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received …

Rare Cases Of COVID Returning Pose Questions For Pfizer Pill
2 years, 10 months ago

Rare Cases Of COVID Returning Pose Questions For Pfizer Pill

Huff Post  

FILE - In this photo provided by Pfizer, a lab technician visually inspects COVID-19 Paxlovid tablet samples in Freiburg, Germany in December 2021. As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. via Associated Press WASHINGTON — As more doctors …

Third Covid-19 vaccine dose offers ‘prolonged immune response’ – UK-wide study
2 years, 11 months ago

Third Covid-19 vaccine dose offers ‘prolonged immune response’ – UK-wide study

The Independent  

Get the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning Headlines email Sign up to our free Morning Headlines email SIGN UP I would like to be emailed about offers, events and updates from The Independent. The Cov-Boost study, led by the University Hospital Southampton, compared immune responses to seven …

Pfizer asks FDA to allow extra-low doses of COVID vaccine for kids under 5
3 years, 1 month ago

Pfizer asks FDA to allow extra-low doses of COVID vaccine for kids under 5

India TV News  

Highlights This would potentially open way for youngest Americans to start receiving shots as early as March The FDA had urged Pfizer and its partner BioNTech to apply earlier than the companies had planned The nation’s 19 million children under 5 are the only group not yet eligible for vaccination Pfizer on Tuesday asked the U.S. to authorize extra-low doses …

EU reviewing Pfizer's COVID antiviral pill for emergency use
3 years, 4 months ago

EU reviewing Pfizer's COVID antiviral pill for emergency use

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The European Union's drug regulator …

Pfizer asks FDA to OK COVID-19 booster shots for all adults
3 years, 4 months ago

Pfizer asks FDA to OK COVID-19 booster shots for all adults

LA Times  

Pfizer says its new study concluded that its booster could restore protection against symptomatic COVID-19 infection to nearly 96%. Pfizer’s new study concluded a booster could restore protection against symptomatic infection to about 95%, even as the extra-contagious Delta variant was surging. Researchers tracked any infections that occurred at least a week later, and so far have counted five cases …

Pfizer-BioNTech covid-19 vaccine for young children to be reviewed by FDA advisers
3 years, 5 months ago

Pfizer-BioNTech covid-19 vaccine for young children to be reviewed by FDA advisers

Live Mint  

Experts advising the Food and Drug Administration are scheduled to meet Tuesday to consider endorsing the Covid-19 vaccine from Pfizer Inc. and BioNTech SE for use in young children. The FDA last week said the results from the companies’ late-stage study met the criteria for immune responses in children 5 to 11 years. After the FDA’s action, the Centers for …

Pfizer-BioNTech COVID vaccine appears more than 90% effective in kids 5 to 11
3 years, 5 months ago

Pfizer-BioNTech COVID vaccine appears more than 90% effective in kids 5 to 11

NPR  

Pfizer-BioNTech COVID vaccine appears more than 90% effective in kids 5 to 11 Enlarge this image toggle caption Mario Tama/Getty Images Mario Tama/Getty Images Pfizer and its partner BioNTech say their data supports authorization of their COVID-19 vaccine in kids 5 to 11. The Food and Drug Administration released the companies' briefing document Friday morning in a prelude to a …

Pfizer-BioNTech report high efficacy of COVID boosters in study
3 years, 5 months ago

Pfizer-BioNTech report high efficacy of COVID boosters in study

Al Jazeera  

The companies say phase III trial data show booster shot of COVID-19 vaccine was 95.6 percent effective against the disease. American pharmaceutical company Pfizer and its partner BioNTech have said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the coronavirus, including the Delta variant. They said a trial of 10,000 …

Full FDA approval of Pfizer’s Covid-19 vaccine had only a modest impact on uptake. Here’s what mattered more
3 years, 5 months ago

Full FDA approval of Pfizer’s Covid-19 vaccine had only a modest impact on uptake. Here’s what mattered more

CNN  

CNN — Despite hopes that full approval of Pfizer’s Covid-19 vaccine would convince large numbers of vaccine-hesitant Americans to roll up their sleeves, a federal government analysis provided to CNN suggests approval was not a silver bullet. The data backs up what a recent poll found: While full approval might matter to some unvaccinated Americans, it’s likely not going to …

Q&A: Why COVID-19 booster shots turned out to be more complicated than vaccines
3 years, 6 months ago

Q&A: Why COVID-19 booster shots turned out to be more complicated than vaccines

LA Times  

Just a few months ago, the protection offered by COVID-19 vaccines brought Americans joy and relief, allowing the fully immunized to ditch their masks and return to a semblance of pre-pandemic life. For instance, in declining to recommend that a third dose of the Pfizer-BioNTech vaccine be made available to all who got their second dose at least six months …

Latest Data On COVID-19 Infections Show Cases Are Dropping
3 years, 6 months ago

Latest Data On COVID-19 Infections Show Cases Are Dropping

NPR  

Latest Data On COVID-19 Infections Show Cases Are Dropping New COVID-19 cases dropped by 20% over the last two weeks. Millions of people who received the Pfizer vaccine are now eligible if it's been at least six months since their second dose. AUBREY: Well, the way the booster strategy and the recommendations are written, there are sort of two categories …

The Latest: Pfizer close to big step toward kids' vaccine
3 years, 6 months ago

The Latest: Pfizer close to big step toward kids' vaccine

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy WASHINGTON — Pfizer’s CEO …

FDA backs Pfizer COVID-19 boosters for seniors, high-risk
3 years, 6 months ago

FDA backs Pfizer COVID-19 boosters for seniors, high-risk

Associated Press  

The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots. FDA acting commissioner Dr. Janet Woodcock said in a statement that the FDA authorization would allow for boosters in …

FDA nod for Pfizer COVID-19 boosters for seniors, high-risk but hurdles remain
3 years, 6 months ago

FDA nod for Pfizer COVID-19 boosters for seniors, high-risk but hurdles remain

Firstpost  

The US has already authorised third doses of the Pfizer and Moderna vaccines for certain people with weakened immune systems such as cancer patients and transplant recipients The US moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed …

The FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID
3 years, 6 months ago

The FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID

NPR  

The FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID Enlarge this image toggle caption Emily Elconin/Getty Images Emily Elconin/Getty Images The Food and Drug Administration authorized a booster dose Wednesday of the Pfizer-BioNTech COVID-19 vaccine for people 65 and older and others at high risk of severe COVID-19. Sponsor Message "After considering the totality …

FDA backs Pfizer COVID-19 boosters for seniors and those at high risk
3 years, 6 months ago

FDA backs Pfizer COVID-19 boosters for seniors and those at high risk

LA Times  

The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of the extra shots. The FDA authorized booster doses for Americans 65 and older, younger people with underlying health conditions and those …

Pfizer Vaccine Still Effective, FDA Says Days Before Review Of Booster Proposal
3 years, 6 months ago

Pfizer Vaccine Still Effective, FDA Says Days Before Review Of Booster Proposal

Huff Post  

LOADING ERROR LOADING The Food and Drug Administration released a review of Pfizer’s application for a COVID-19 booster shot on Wednesday, saying that although the third shots increased immune responses in study participants, the company’s vaccine was holding up strongly against severe forms of the virus without an additional shot. Pfizer noted in its application that its vaccine’s effectiveness against …

FDA Experts Are Among A Group That Opposes The U.S. Booster Shot Plan
3 years, 6 months ago

FDA Experts Are Among A Group That Opposes The U.S. Booster Shot Plan

NPR  

FDA Experts Are Among A Group That Opposes The U.S. Booster Shot Plan Enlarge this image toggle caption Jae C. Hong/AP Jae C. Hong/AP The average person doesn't need a COVID-19 booster yet, an international group of scientists — including two top U.S. regulators — wrote Monday in a scientific journal. Sponsor Message The White House has announced plans to …

COVID-19 vaccine program would be further behind if government focused on Pfizer, PM says
3 years, 6 months ago

COVID-19 vaccine program would be further behind if government focused on Pfizer, PM says

ABC  

The Australian COVID-19 vaccine program would be even further behind if the government had depended on Pfizer vaccines for its rollout, the Prime Minister says, as his government faces suggestions it was late to make a deal with the company. Key points: The Prime Minister says a locally made vaccine strategy has doubled the country's current vaccination rate The Prime …

80 per cent COVID-19 immunity lost in 6 months in some after Pfizer shot: US study
3 years, 6 months ago

80 per cent COVID-19 immunity lost in 6 months in some after Pfizer shot: US study

Deccan Chronicle  

Washington: COVID-19 antibodies produced by the Pfizer vaccine decreased more than 80 per cent in senior nursing home residents and their caregivers six months after receiving their second dose, a US study has found. The research led by Case Western Reserve University and Brown University in the US studied blood samples of 120 nursing home residents and 92 health care …

Column: Following FDA approval of Pfizer’s shot, the anti-vaccine movement cooks up new conspiracy theory
3 years, 6 months ago

Column: Following FDA approval of Pfizer’s shot, the anti-vaccine movement cooks up new conspiracy theory

LA Times  

Robert F. Kennedy Jr., leading anti-vaccine activist and son of the slain U.S. senator, after leaving a meeting with President-elect Trump in 2017. — William Schaffner, Vanderbilt University Reduced to its essentials, the new claim is that the FDA didn’t really grant full authorization to the Pfizer vaccine, which has been christened Comirnaty. Here’s Robert F. Kennedy Jr., a leading …

What does full approval of Pfizer’s COVID-19 vaccine mean?
3 years, 7 months ago

What does full approval of Pfizer’s COVID-19 vaccine mean?

India TV News  

It means Pfizer’s shot for people 16 and older has now undergone the same rigorous testing and regulatory review as dozens of other long-established vaccines. COVID-19 vaccines in the U.S. were initially rolled out under the Food and Drug Administration’s emergency use authorization, which allows the agency to speed the availability of medical products during public health emergencies. Under the …

FDA Grants Full Approval to Pfizer-BioNTech COVID-19 Vaccine
3 years, 7 months ago

FDA Grants Full Approval to Pfizer-BioNTech COVID-19 Vaccine

The Quint  

The United States Food and Drug Administration on Monday, 23 August, granted full approval to Pfizer-BioNTech COVID-19 vaccine, making it the first COVID-19 vaccine to move past the emergency approval status in the US. The US Food and Drug Administration's acting commissioner Janet Woocock said, "the FDA's approval of this vaccine is a milestone as we continue to battle the …

Slew of new mandates announced after FDA grants full approval to Pfizer vaccine
3 years, 7 months ago

Slew of new mandates announced after FDA grants full approval to Pfizer vaccine

Salon  

The Food and Drug Administration on Monday officially granted full legal approval to Pfizer's COVID-19 vaccine, opening the floodgates to a slew of new vaccination mandates. Pfizer's shot, developed in conjunction with German biotechnology company BioNTech, is the first to gain full FDA approval, with Moderna and Johnson & Johnson still under authorization for emergency use. "The FDA's approval of …

US grants full safety approval to Pfizer COVID-19 vaccine
3 years, 7 months ago

US grants full safety approval to Pfizer COVID-19 vaccine

Al Jazeera  

FDA decision paves the way for wider distribution of jabs and vaccine’s legal mandates in the US. The United States Food and Drug Administration has given full safety approval to Pfizer and BioNTech’s COVID-19 vaccine in a landmark decision that will allow leading US employers and universities to mandate jabs. “With today’s FDA full approvals there’s another good reason to …

U.S. regulators give full approval to Pfizer COVID-19 vaccine
3 years, 7 months ago

U.S. regulators give full approval to Pfizer COVID-19 vaccine

LA Times  

The U.S. Food and Drug Administration has granted full approval to the Pfizer-BioNTech vaccine for people 16 and older, an endorsement that experts hope will dramatically boost vaccination rates. “The public can be very confident that this vaccine meets the high standards for safety, effectiveness and manufacturing quality the FDA requires of an approved product,” said Dr. Janet Woodcock, the …

Pfizer-BioNTech's COVID Vaccine Gets Full Approval From The FDA
3 years, 7 months ago

Pfizer-BioNTech's COVID Vaccine Gets Full Approval From The FDA

NPR  

Pfizer-BioNTech's COVID Vaccine Gets Full Approval From The FDA Enlarge this image toggle caption Patrick T. Fallon/AFP via Getty Images Patrick T. Fallon/AFP via Getty Images The Food and Drug Administration has formally approved Pfizer's COVID-19 vaccine. "While this and other vaccines have met the FDA's rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the …

Pfizer-BioNtech submit data to health authorities for approval of third COVID-19 vaccine
3 years, 7 months ago

Pfizer-BioNtech submit data to health authorities for approval of third COVID-19 vaccine

Firstpost  

The companies plan to submit the same information to European authorities in the coming weeks. Pfizer and BioNTech on Monday submitted preliminary clinical data to US health authorities as part of their effort to seek authorization for a third dose of their Covid-19 vaccine for all Americans. “The data we’ve seen to date suggest a third dose of our vaccine …

Pfizer submits initial trial data to FDA for COVID-19 vaccine booster
3 years, 7 months ago

Pfizer submits initial trial data to FDA for COVID-19 vaccine booster

Daily Mail  

Pfizer and BioNTech have submitted initial clinical trial data for their joint COVID-19 vaccine booster shot to the U.S. Food and Drug Administration. Pfizer and BioNTech submitted initial clinical trial data of a third COVID-19 vaccine shot to the FDA. Pictured: A nurse prepares a shot of the Pfizer vaccine, August 2021 Pfizer's booster shot showed increased effectiveness against the …

New COVID-19 vaccine warnings don’t mean it’s unsafe
3 years, 8 months ago

New COVID-19 vaccine warnings don’t mean it’s unsafe

Salon  

While the COVID-19 vaccines currently available in the U.S. have been proved to be safe and effective, recent reports of rare adverse events, or side effects, have raised concerns. On July 12, 2021, the Food and Drug Administration approved an update to the Johnson & Johnson COVID-19 vaccine fact sheet to include an increased risk of the rare nerve condition …

'I take responsibility': Prime Minister acknowledges COVID-19 vaccine rollout failures, as one million weekly doses mark reached
3 years, 8 months ago

'I take responsibility': Prime Minister acknowledges COVID-19 vaccine rollout failures, as one million weekly doses mark reached

ABC  

Prime Minister Scott Morrison says he takes responsibility for the slow COVID-19 vaccine rollout, but that the country is now tracking well with the vaccination program. Key points: One million people received a COVID-19 vaccination in the past seven days One million people received a COVID-19 vaccination in the past seven days The Government expects to receive advice on a …

Dangerous trend: WHO warns against mixing and matching Covid vaccines
3 years, 8 months ago

Dangerous trend: WHO warns against mixing and matching Covid vaccines

India Today  

The World Health Organisation's chief scientist on Monday advised against people mixing and matching Covid-19 vaccines from different manufacturers, calling it a "dangerous trend" since there was little data available about the health impact. Infectious disease experts are weighing whether people who received Johnson & Johnson's single-dose vaccine should receive a booster of the Pfizer or Moderna mRNA-based vaccine which …

Pfizer to meet US officials over COVID vaccine booster
3 years, 8 months ago

Pfizer to meet US officials over COVID vaccine booster

Al Jazeera  

US chief medical adviser Anthony Fauci has said it is too soon for the government to recommend a third booster shot. Pfizer says it plans to meet with top United States health officials on Monday to discuss the drugmaker’s request for federal authorisation of a third dose of its COVID-19 vaccine, as President Joe Biden’s chief medical adviser Anthony Fauci …

Covid -19: Pfizer and BioNTech seek approval for a vaccine booster
3 years, 8 months ago

Covid -19: Pfizer and BioNTech seek approval for a vaccine booster

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Within weeks, Pfizer and its partner BioNTech plan to ask US …

Pfizer, Moderna Vaccines Cut Covid-19 Risk by 91 Per Cent: Study
3 years, 8 months ago

Pfizer, Moderna Vaccines Cut Covid-19 Risk by 91 Per Cent: Study

News 18  

People who receive Covid-19 vaccines by Pfizer and Moderna are up to 91 per cent less likely to develop the disease, according to a US study which also suggests that the preventives reduce the severity of symptoms and duration in those who still get an infection. The study found that mRNA Covid-19 vaccines were 91 per cent effective in reducing …

FDA adds heart inflammation warning to Moderna, Pfizer vaccines
3 years, 9 months ago

FDA adds heart inflammation warning to Moderna, Pfizer vaccines

Al Jazeera  

Warning update follows an extensive review of information and discussion by CDC’s Advisory Committee. The US Food and Drug Administration has added a warning about the risk of heart inflammation to fact sheets for Moderna and Pfizer-BioNTech COVID-19 vaccines. The warning on Friday noted that reports of adverse events following vaccination – particularly after the second dose – suggest increased …

Pfizer's Covid vaccine in final stages of getting approval in India: CEO Albert Bourla
3 years, 9 months ago

Pfizer's Covid vaccine in final stages of getting approval in India: CEO Albert Bourla

India Today  

Pfizer is now in the final stages of getting emergency use approval for its Covid-19 vaccine in India, said the company's Chairman and CEO, Albert Bourla. READ: Pfizer to test Covid-19 vaccine in larger group of children below 12 NITI Aayog member Dr VK Paul told CNBC-TV18 on Monday that the central government is in talks with Pfizer and other …

American Phrama Pfizer To Begin Testing Covid Vaccine On Children Below 12
3 years, 9 months ago

American Phrama Pfizer To Begin Testing Covid Vaccine On Children Below 12

ABP News  

New Delhi: American pharmaceutical company Pfizer on Tuesday said that a large study will begin to test its Covid vaccine in children below 12 and selected a dosing regime for the trial. Recently, European Medicines Agency approved the Pfizer/BioNTech Covid vaccines for the age group 12 to 15 years, making it the first vaccine to get the green light for …

Pfizer vaccine for 12 to 15 age bracket approved by UK regulator after 'rigorous review'
3 years, 9 months ago

Pfizer vaccine for 12 to 15 age bracket approved by UK regulator after 'rigorous review'

Firstpost  

The Medicines and Healthcare products Regulatory Agency approved the two-shot jab following clinical trials among younger age groups, saying the vaccine had met the expected standards of safety, quality and effectiveness London: Britain’s medicines regulator said Friday the Pfizer/BioNTech vaccine is safe for adolescents aged 12 to 15 after a “rigorous review”, following similar assessments in the European Union and …

UK Regulator Approves Pfizer Jab for Children Aged 12 to 15 Years After 'Rigorous Review'
3 years, 9 months ago

UK Regulator Approves Pfizer Jab for Children Aged 12 to 15 Years After 'Rigorous Review'

News 18  

Britain’s medicines regulator said Friday the Pfizer/BioNTech vaccine is safe for adolescents aged 12 to 15 after a “rigorous review”, following similar assessments in the European Union and United States. The Medicines and Healthcare products Regulatory Agency approved the two-shot jab following clinical trials among younger age groups, saying the vaccine had met the “expected standards” of safety, quality and …

Pfizer vaccine approved for children in age group 12 to 15: UK Regulator
3 years, 9 months ago

Pfizer vaccine approved for children in age group 12 to 15: UK Regulator

India TV News  

Pfizer-BioNTech vaccine against coronavirus has been approved by UK regulator for 12 to 15-year-old children, AFP reported on Friday. Last week, the European Medicines Agency recommended that the use of the coronavirus vaccine made by Pfizer and BioNTech be expanded to children ages 12 to 15, a decision that offers younger and less at-risk populations across the continent access to …

EU regulator backs Pfizer-BioNTech Covid-19 vaccine for adolescents
3 years, 10 months ago

EU regulator backs Pfizer-BioNTech Covid-19 vaccine for adolescents

India Today  

Europe's medicines regulator on Friday backed the use of Pfizer's Covid-19 vaccine for children as young as 12, paving way for a broader roll-out in the region after similar clearances in the United States and Canada. The European Medicines Agency's endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany's BioNTech, to include 12- to …

Told India no safety concern with its Covid-19 vaccine: Pfizer
3 years, 10 months ago

Told India no safety concern with its Covid-19 vaccine: Pfizer

India Today  

Pfizer Inc said on Monday it told the Indian government that there was no concern over the safety of its COVID-19 vaccine, as the country insists on small local trials for foreign shots despite a record surge in infections and shortage of doses. The government in mid-April made it easier for foreign vaccines approved in the West and Japan to …

COVID-19 vaccine timeline: 1st and 2nd dose do's and don'ts
3 years, 11 months ago

COVID-19 vaccine timeline: 1st and 2nd dose do's and don'ts

LA Times  

Serious side effects do happen, but how common are they? For every million doses of the COVID-19 vaccine given, approximately how many reports of a serious reaction have there been? The risk of adverse reactions after vaccination is extremely low — especially compared with the likelihood of becoming seriously ill with COVID-19. From the start of the vaccine rollout through …

US begins study assessing allergic reactions to Pfizer, Moderna Covid vaccines
3 years, 11 months ago

US begins study assessing allergic reactions to Pfizer, Moderna Covid vaccines

Hindustan Times  

US' National Institutes of Health announced on Wednesday that it is launching a study to determine the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals. A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an immediate and systemic allergic reaction …

Discover Related